Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

Understanding Allergies

The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease

Study Overview

• Status: Recruiting
• Conditions: Allergy

• Study Type: Observational
• Enrollment (Estimated): 2500

Contacts and Locations

• Study Contact: Name: SNP Center Inquiry; Phone Number: (650) 521-7237; Email: snpcenterallergy_inquiry@stanford.edu

Study Locations

• United States
  • California
    • Palo Alto, California, United States, 94304
      • Recruiting
      • Sean N. Parker Center for Allergy and Asthma Research, Stanford University
      • Contact: SNP Center Inquiry; Phone Number: 650-521-7237; Email: snpcenterallergy_inquiry@stanford.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 1 week to 90 years (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Patients ages 1 week through 90 years who have or are suspected of having allergic sensitivities will be invited to participate

Description

Inclusion Criteria:

• Any individual with possible allergy

Exclusion Criteria:

• Patients with special risks attendant to venipuncture will be excluded

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Skin testing to evaluate food allergen responses	Standardized skin testing performed to detect sensitivity to allergens of interest	1 year

Collaborators and Investigators

• Sponsor: Stanford University
• Collaborators: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); National Human Genome Research Institute (NHGRI); Harvard School of Public Health (HSPH); Crown Fundation; Sunshine Foundation
• Investigators: Principal Investigator: R. Sharon Chinthrajah, MD, Stanford University

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2007
• Primary Completion (Estimated): December 1, 2028
• Study Completion (Estimated): December 1, 2028

Study Registration Dates

• First Submitted: March 30, 2021
• First Submitted That Met QC Criteria: March 30, 2021
• First Posted (Actual): April 2, 2021

Study Record Updates

• Last Update Posted (Actual): March 17, 2026
• Last Update Submitted That Met QC Criteria: March 16, 2026
• Last Verified: March 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Immune System Diseases; Hypersensitivity
• Other Study ID Numbers: 8629; 1R01AI165866-01 (U.S. NIH Grant/Contract); 1DP2HG012480-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No